Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Aligos Therapeutics, Inc.”

32 pharma patents match "Aligos Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 32
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 32 pharmaceutical patents matching "Aligos Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

32 results for “Aligos Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11466274

    Modified gapmer oligonucleotides and methods of use

    Aligos Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  2. US 11464783

    Heterocyclic compounds

    Aligos Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  3. US 11198699

    Compounds targeting PRMT5

    Aligos Therapeutics, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  4. US 11191747

    Pyrrole compounds

    Aligos Therapeutics, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted
  5. US 11166976

    S-antigen transport inhibiting oligonucleotide polymers and methods

    Aligos Therapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  6. US 11136321

    Tricyclic compounds

    Aligos Therapeutics, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  7. US 11091467

    Modulators of THR-β and methods of use thereof

    Aligos Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  8. US 11033556

    Bicyclic sulfonamides

    Aligos Therapeutics, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted